World Menopause Day: Prioritizing Women’s Well-Being and Gynecological Health
October 18th marks World Menopause Day, a day dedicated to acknowledging women navigating this natural phase of life. This year, Fidia reaffirms its commitment to raising awareness about menopause, focusing on gynecological health to support women’s well-being.
Menopause brings significant changes, often accompanied by various symptoms, with vaginal dryness being one of the most common. This condition, which affects 55% of menopausal women, is more prevalent than many realize. It is primarily caused by a drop in estrogen levels and also affects 70% of women with breast cancer and 30% of those who use oral contraceptives. Additionally, 43% of women experience this symptom temporarily during the postpartum period. This condition can lead to itching and burning, significantly impacting women’s daily quality of life.
The dryness of the vaginal mucosa, often accompanied by reduced elasticity, increases the risk of lesions and decreases natural lubrication2. Vaginal dryness can cause pain during sexual intercourse, with 55% of menopausal women reporting discomfort during sexual activity, leading to a decrease in sexual desire in 46% of them. Such issues can impact the bond between partners, as well as affect self-esteem and overall well-being1.
Fidia encourages women to take an active role in managing their health, especially during menopause, by consulting with specialized healthcare professionals. Addressing menopausal symptoms through suitable treatments, such as moisturizers containing Hyaluronic Acid, can help restore tissue function and improve comfort. Hyaluronic Acid, a natural substance in the body, binds with water molecules to ensure tissue hydration and ease symptoms4.
To effectively manage menopausal symptoms and feel empowered throughout this phase, it is important to discuss tailored solutions with a gynecologist.
Bibliography
1. Nappi, R.E., et al. (2013). The CLOSER (Clarifying Vaginal Atrophy’s Impact On Sex and Relationships) survey: implications of vaginal discomfort in postmenopausal women and in male partners. Journal of Sexual Medicine, 10(9), 2232-41. doi: 10.1111/jsm.12235.
2. MacBride, M.B., et al. (2010). Vulvovaginal Atrophy. Mayo Clinic Proceedings, 85(1), 87-94.
3. Bachmann, G.A. (2000). Diagnosis and Treatment of Atrophic Vaginitis. American Family Physician, 61(10), 3090-6.
4. Nappi, R.E., et al. (2020). Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women. Climacteric, 23(5), 519-24. doi: 10.1080/13697137.2020.1754386.